GSK Bactroban Generics Petition Cites FDA Topical Bioequivalence Methods
Executive Summary
A citizen petition from GlaxoSmithKline seeking to block Bactroban Cream (mupirocin) generics revisits the question of whether generics of topical dermatologic drug products containing different forms of the active ingredient should be approved by FDA